Not currently recruiting at UCSF
A Study of TCD601 in the Induction of Tolerance in de Novo Renal Transplantation (PANORAMA)
Summary
- Eligibility
- for people ages 18-60 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Sandy Feng, MD, PhD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Sandy Feng, MD, PhD
Dr. Sandy Feng is a transplant surgeon who performs liver, kidney and pancreas transplants. In her research, Feng studies transplantation tolerance, a transplant recipient's ability to maintain normal organ function with minimal or no use of immunosuppressive drugs.
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- ITB-Med LLC
- ID
- NCT04803006
- Phase
- Phase 2 Kidney Transplant Research Study
- Study Type
- Interventional
- Participants
- Expecting 18 study participants
- Last Updated